This will be filed for cardiac tamponade requiring intervention.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 4.One clip was implanted, reducing mr to 1.After the procedure, the patient experienced cardiac tamponade.A pericardial effusion could not be confirmed.Pericardiocentesis was performed as treatment.There was no clinically significant delay in the procedure and no adverse patient sequela.No additional information was provided.
|
The products were not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.In this case, there was no reported device malfunction associated with the steerable guide catheter (sgc) devices.Based on the information provided, a cause for the report cardiac tamponade could not be determined.The reported patient effect of cardiac tamponade, as listed in the mitraclip system g4 instructions for use, is a known possible complication associated with mitraclip procedures.The reported unexpected medical intervention was a result of case-specific circumstances as pericardiocentesis was performed to treat cardiac tamponade.There is no indication of a product issue with respect to manufacture, design, or labeling.
|